1. Home
  2. BNZI vs APVO Comparison

BNZI vs APVO Comparison

Compare BNZI & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNZI
  • APVO
  • Stock Information
  • Founded
  • BNZI 2016
  • APVO 2016
  • Country
  • BNZI United States
  • APVO United States
  • Employees
  • BNZI N/A
  • APVO N/A
  • Industry
  • BNZI
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNZI
  • APVO Health Care
  • Exchange
  • BNZI Nasdaq
  • APVO Nasdaq
  • Market Cap
  • BNZI 8.9M
  • APVO 6.5M
  • IPO Year
  • BNZI N/A
  • APVO N/A
  • Fundamental
  • Price
  • BNZI $1.54
  • APVO $4.00
  • Analyst Decision
  • BNZI Strong Buy
  • APVO Strong Buy
  • Analyst Count
  • BNZI 1
  • APVO 1
  • Target Price
  • BNZI $125.00
  • APVO $296.00
  • AVG Volume (30 Days)
  • BNZI 4.5M
  • APVO 46.8K
  • Earning Date
  • BNZI 02-28-2025
  • APVO 03-04-2025
  • Dividend Yield
  • BNZI N/A
  • APVO N/A
  • EPS Growth
  • BNZI N/A
  • APVO N/A
  • EPS
  • BNZI N/A
  • APVO N/A
  • Revenue
  • BNZI $4,310,782.00
  • APVO N/A
  • Revenue This Year
  • BNZI $5.58
  • APVO N/A
  • Revenue Next Year
  • BNZI $58.87
  • APVO N/A
  • P/E Ratio
  • BNZI N/A
  • APVO N/A
  • Revenue Growth
  • BNZI N/A
  • APVO N/A
  • 52 Week Low
  • BNZI $1.21
  • APVO $3.65
  • 52 Week High
  • BNZI $80.00
  • APVO $399.60
  • Technical
  • Relative Strength Index (RSI)
  • BNZI 47.76
  • APVO 36.27
  • Support Level
  • BNZI $1.48
  • APVO $3.91
  • Resistance Level
  • BNZI $1.81
  • APVO $4.47
  • Average True Range (ATR)
  • BNZI 0.27
  • APVO 0.30
  • MACD
  • BNZI -0.00
  • APVO 0.05
  • Stochastic Oscillator
  • BNZI 21.23
  • APVO 18.40

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: